A Study of Guselkumab in Participants With Systemic Sclerosis

See also
Status	Clinical Trial	Phase
Completed	`NCT03965780` - The SPIN - Scleroderma Support Group Leader EDucation Program Trial (SPIN-SSLED)	N/A
Terminated	`NCT02558543` - Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis	Phase 2
Withdrawn	`NCT01202045` - Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients	N/A
Terminated	`NCT01445821` - Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial	Phase 3
Recruiting	`NCT05878717` - A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease	Phase 3
Recruiting	`NCT03559465` - Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.	N/A
Not yet recruiting	`NCT03610217` - Pragmatic Clinical Trials in Scleroderma	N/A
Completed	`NCT02655640` - The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic Sclerosis	N/A
Completed	`NCT05622578` - Phenotyping of Chronic Pain in Diffused Systemic Scleroderma	N/A
Recruiting	`NCT04804930` - Trichoscopy and Systemic Scleroderma
Completed	`NCT03675581` - A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)	Phase 1
Completed	`NCT03221257` - Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate	Phase 2
Recruiting	`NCT05559580` - A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms	Phase 2
Completed	`NCT00442611` - A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)	Phase 1/Phase 2
Completed	`NCT00001330` - Study of Silicone-Associated Connective Tissue Diseases	N/A
Completed	`NCT02597933` - A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis	Phase 3
Not yet recruiting	`NCT05821335` - Leap Motion Based Gamefication Exercises in the Individuals With Systemic Sclerosis	N/A
Completed	`NCT00333437` - Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement	N/A
Completed	`NCT00025818` - Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome	Phase 3
Not yet recruiting	`NCT05351060` - Novel Splinting Technique Using 3D Models	N/A

NCT number	NCT04683029
Study type	Interventional
Source	Janssen Pharmaceutical K.K.
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	February 24, 2021
Completion date	July 5, 2024

A Study of Guselkumab in Participants With Systemic Sclerosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms